The headline reads as positive (95% confidence from the FinBERT financial-language model), so the stock went through the full analysis. The broader analysis agrees with the good news.
Stocks › ACA
Arcosa, Inc. (ACA) stock analysis
WEAK BUY 15% confidence · analysed Oct 29, 2026
On Oct 29, 2026, our model rated Arcosa, Inc. (ACA) WEAK BUY with 15% confidence at a price of $149.15. That means the signals lean positive, but they are mixed, so conviction is low.
Analysed price$149.15
Technical picture
The 14-day RSI is 85, above 70, which is overbought: buyers have been very aggressive and a pause or pullback is common from here.
MACD is above its signal line, a sign that short-term momentum is turning up.
The price is above both its 50-day and 200-day moving averages, the classic picture of an uptrend.
Volume is about normal (1.4x the 20-day average).
Trend structure and money flow
Market structure shows a bullish break of structure (BOS): price broke a recent swing high in the direction of the trend, which usually signals trend continuation.
The most recent swing high is $146.82 and the swing low is $143.90; traders often treat these as resistance and support.
Price is sitting in a bearish order block, a zone where large sellers stepped in before, so upside may stall here.
Fundamentals
The PEG ratio is 1.90, which looks reasonably priced for its growth.
The company reports a profit margin of 16.8% and revenue growth of +1.7%.
The next earnings report is expected around Oct 29, 2026; prices often move sharply around earnings.
Trade plan from the model
The model's long / bullish plan uses an entry near $149.15, a target of $149.84 (+0.5%) and a stop-loss at $148.04 (-0.7%).
That is a reward-to-risk ratio of about 0.6 to 1: the potential loss is bigger than the gain, a weak setup.
The plan has a time limit: reassess by Nov 8, 2026 whatever the price does.
Entry$149.15
Target$149.84
Stop-loss$148.04
Reassess byNov 8, 2026
Research notes
ACA is ambiguous: Crédit Agricole (Euronext Paris) screens as the value case, with roughly 7.7× trailing earnings, 0.66× book value, an approximately 11% dividend yield, and expected earnings growth of about 8.7% annually. The bear case is execution and valuation uncertainty: the dividend record is described as unstable, analyst targets have been mixed or trimmed, and the shares were recently well below their 50-day and 200-day averages. A recent potential catalyst is Crédit Agricole’s reported bid for Barclays’ German consumer-finance unit, which could expand its platform but also add acquisition and integration risk. If “ACA” refers instead to Arcosa, the major catalyst is CRH’s completed $8.5 billion acquisition, while the bear case is that the stock’s valuation already prices in substantial infrastructure and earnings upside.
The model's one-paragraph read
Leans BUY — composite score +0.15 (WEAK BUY). Technicals: RSI 85.34, MACD bullish, price above SMA50. Fundamentals: PEG 1.90, margin 16.8%, revenue growth 1.7%. Financial results: YoY revenue +1.7%, next earnings 2026-10-29. Smart Money Concepts: BOS bullish (trend continuation), price retesting a bearish order block. FinGPT news read: positive. Internet research: ACA is ambiguous: **Crédit Agricole (Euronext Paris)** screens as the value case, with roughly 7.7× trailing earnings, 0.66× book value, an approximately 11% dividend yield, and expected earnings growth of about 8.7% annually. The bear case is execution and valuation uncertainty: the dividend record is described as unstable, analyst targets have been mixed or trimmed, and the shares were recently well below their 50-day and 200-day averages. A recent potential catalyst is Crédit Agricole’s reported bid for Barclays’ German consumer-finance unit, which could expand its platform but also add acquisition and integration risk. If “ACA” refers instead to **Arcosa**, the major catalyst is CRH’s completed $8.5 billion acquisition, while the bear case is that the stock’s valuation already prices in substantial infrastructure and earnings upside. Suggested levels: entry $149.15, target $149.84, stop-loss $148.04, exit by 2026-11-08 (10-calendar-day max hold (time-stop; reassess by this date regardless of P&L)).
Past ratings for ACA
| Date | Verdict | Confidence | Price | Move since | |
|---|---|---|---|---|---|
| Oct 29, 2026 | WEAK BUY | 15% | $149.15 | — |
"Move since" compares each call's price with the latest analysed price.
Recent news on ACA
Oct 29, 2026 · CRH plc Reports Q3 2026 Results, Completes $8.5B Arcosa Acquisition, and Announces $6B Share Buyback
- Oct 29, 2026: CRH plc Reports Q3 2026 Results, Completes $8.5B Arcosa Acquisition, and Announces $6B Share Buyback (Nasdaq)
Frequently asked questions
Is ACA a buy right now?
As of Oct 29, 2026, our automated model rates Arcosa, Inc. (ACA) WEAK BUY with 15% confidence: the signals lean positive, but they are mixed, so conviction is low. This is a model output for education, not personal investment advice.
What is the price target for ACA?
The model's most recent plan targets $149.84 with a stop-loss at $148.04, from an entry near $149.15.
When does Arcosa, Inc. report earnings next?
The next earnings report is expected around Oct 29, 2026.
What does a WEAK BUY rating mean?
A WEAK BUY rating means the signals lean positive, but they are mixed, so conviction is low.
For information and education only. Not investment advice. Ratings are produced by an automated model, can be wrong, and may be out of date. Do your own research; you can lose money investing. The site's author may hold positions in stocks discussed here.